Zhejiang Huahai Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥22.85 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	19.97
Forward PE	16.93
Price to Sales TTM	CN¥2.44
Price to Book MRQ	CN¥2.64
Enterprise to Revenue	3.01
Enterprise to EBITDA	10.83

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	12.20%
Operating Margin	24.62%
Return on Assets TTM	5.85%
Return on Equity TTM	13.26%

Income Statement

Revenue TTM	CN¥9,348,809,728
Revenue per Share TTM	CN¥6.42
Quarterly Revenue Growth	10.80%
Gross Profit TTM	CN¥5,814,240,768
EBITDA	CN¥1,955,842,079
Net Income to Common TTM	CN¥1,140,177,408
Diluted EPS TTM	CN¥0.78
Quarterly Earnings Growth YoY	85.10%

Balance Sheet

Total Cash MRQ	CN¥1,517,234,176
Total Cash per Share MRQ	CN¥1.05
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	77.51
Current Ratio MRQ	1.40
Book Value per Share MRQ	CN¥5.90

Cash Flow

Operating Cash Flow TTM	CN¥2,642,683,648
Levered Free Cash Flow TTM	CN¥730,606,784

600521 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,466,759,936
Float Shares	842,115,504
Avg 10 Volume	20,697,475
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	41.64%
% Held by Institutions	12.56%

Stock Price Summary

Beta	0.09
Fifty Two Week Low	CN¥10.71
Fifty Two Week High	CN¥21.55
Fifty Two Week Change	19.19%
Day 50 MA	CN¥17.55
Day 200 MA	CN¥17.31

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	5.13%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	1.28%
Payout Ratio	25.64%
Dividend Date
Ex Dividend Date	2024-07-10
Last Split Factor
Last Split Date	2020-06-08